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Abstract 
The development of new, evidence-based treatments relies on an improved understanding of the often very complex 
pathophysiology of diseases. The systems (bio) medicine approaches have the potential to tackle this complexity through the 
integration of a variety of biological and medical research data and computational modelling. A European collaborative approach 
is required to assemble the necessary multidisciplinary expertise (e.g. biology, medicine, mathematics, computational 
technologies, and economics) to implement these last systems, which are approached in order to reduce the cost of the European 
Public Health System and simultaneously improve the wellbeing among citizens. 
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1. Introduction 
The main objective of our proposal is to emphasize and quantify the economic benefits that the early detection 
and treatment of rare and emergent diseases has on the European countries and society in general. Rare and 
emergent diseases (REDs) are the group of diseases that are not investigated properly due to the lack of information 
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and the small percentage of the population suffering them. Medical experts, vanguard computational engineering 
and a robust set of economic models will be combined in order to create improved medical diagnostics, an 
innovative decision making software intended primarily for practitioners and to precisely quantify the positive 
economic impacts that such efforts represent for European public health systems, searching for scalability to other 
diseases. 
  
2. Materials and methods 
We suggest a methodology managed to know the cause-effect relations that remain hidden when doing a 
causality study between different elements [6-7]. We will start our approach with an uncertain cause-effect matrix 
defined by two groups of elements: 
 
, which act as causes 
 , which act as effects 
 
In addition, a causality relation [M] defined by the matrix: 
being  the characteristic pertinence relations from every single 
element of the matrix [M] (formed by the rows corresponding to the elements from de group A –causes- and the 
columns corresponding to the elements from the group B –effects). We could say, then, that the matrix [M] is 
composed by the estimations formed around all the effects where the elements from the group A exercise over the 
elements from the group B. The more meaningful this incidence relation is, the higher the value of each of the 
elements of the matrix will be. In this case, as we have departed from the fact that the characteristic pertinence 
relation had to take part in the interval [0, 1], we understand that the higher the incidence relation is, the nearer to 1 
the assigned value will result. We must emphasize the fact that this initial matrix [M] is elaborated departing from 
the direct cause-effect relations, in other words, from the first generation. Our aim is based on obtaining a new 
incidence matrix, but reflecting not only the direct causalities, but also the ones, which, even though not being 
evident, still exist and are sometimes vital to appreciate certain facts. For this reason, it’s necessary to build two 
additional incidence relations, which will pick up the possible effects which will come from deriving causes 
between causes (ion one hand) and effects between effects (on the other hand). 
These two auxiliary matrixes are defined as: 
 
 
The matrix [A] picks up the incidence relations, which can be produced between each of the elements, which act 
as causes, and the matrix [B] does the same with the elements, which act as effects. Both [A] and [B] match up the 
fact that both of them are reflexive matrixes, in another way: 
 
 
In addition, they are translated in the fact that one element, cause or effect, has a bearing on itself at the 
maximum presumption. 
In contrast none of [A] or [B] are symmetric matrixes, that is: 
 
 
For obvious reasons. 
Once built the matrixes [M], [A] and [B] the establishment of all possible incidence (direct or indirect) 
combinations must be proceeded. To achieve it, we will realize the max-min composition of the three matrixes: 
A a i / i 1, 2, ..., n
B b j / j 1, 2 , ..., m
M a i b j 0,  1 / i 1,2, ..., n ; j 1,2, ..., m a i b j
A a i a j 0,  1 / i, j 1,2, ..., n
  
B b i b j 0,  1 / i, j 1,2, ..., m
a i a j
1 / i, j 1,2, ..., n
b i b j
1 / i, j 1,2, ..., m
a i a j a j a i
i, j 1,2, ..., n
b i b j b j b i
i, j 1,2, ..., m
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The obtained result will be a new matrix [M*] which picks up the incidences between causes and effects in 
second generation, in other words, the initial causal relations affected by the possible interposed incidence from a 
cause or effect. 
 
 Therefore, the difference between the second-generation effects matrix and the direct incidence matrix will allow 
us to know the level in which some causality relations have been forgotten: 
 
  
We must say, finally, that the higher the pertinence characteristic function value of the matrix [O] is, the higher is 
the forgotten level produced in the initial incidence relation. This is translated in the fact that the implications 
derived from some incidences not considered or taken into account in its fair intensity, can lead to mistaken 
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3. A medical diagnostic approach. The case of the Hereditary Hemochromatosis 
In the medical professional field, we often found ourselves in front of different diseases with common symptoms 
[1-5,8-12]. Sometimes, the symptoms are so similar that we can even mistake the diseases. When a patient comes to 
a surgery, he/she describes several nuisances he/she suffers, which can be initial signs from different diseases, 
sometimes-distant diseases with very different prognostics. In this context, trying to establish links between 
symptoms and diseases with classical models based in probability is not an infallible guarantee in the diagnosis. 
Every symptom is subjective in every patient, and so is his/her perception and feeling of pain and the way they 
describe it to the doctor. That is why objective tests (such as blood analysis or radiographies) and subjective 
estimations (being able to explain a certain level of pain, pills effect or possible allergies) are used. Only this way it 
is possible to obtain the whole incidence relations and the relation level. 
We will start the Forgotten Effects Model application statement showing two groups of elements, which will act 
as causes and effects. Note that the forgotten effects model is based on the concept of fuzzy relations [14], which is 
based on the notion of fuzzy sets [13,15-16]. We will call causes several diseases which could be suffered by a 
patient, and we will call effects the different symptoms which can be cause by the diseases. The main aim is the 
possibility of detecting a disease by a single symptom or group of different symptoms from the usual ones, simply 
because a symptom can happen to be at the same time, symptom of another symptom. We will show the 
mechanisms which can bring the hidden processes recuperation and we will study the incidence level in which can 
be produced. 
Causes (diseases which could cause confusion): 
a1 = Hereditary Hemochromatosis (100%) 
a2 = Arthritis (30-40%) 
a3 = Cirrhosis (60%) 
a4 = Diabetes (50-60%) 
a5 = Fibrosis (60%) 
 
Effects (symptoms caused): 
b1 = Ferrous accumulation in the pituitary glands (15-35%) 
b2 = Testicular atrophy (15-35%) 
b3 = Weakness and tiredness (70-80%) 
b4 = Thyroid dysfunction (15-35%) 
b5 = Stomachache (60%) 
b6 = Hiperresonance to percussion (10%) 
b7 = General darkening of the skin (70%) 
b8 = Heart failure, arrhythmia and angina pectoris (20-30%) 
b9 = Pancreas failure (50-60%) 
b10 = Liver failure (80%) 
b11 = Rare noises in the respiratory tract (40%) 
b12 = Increase of the bacterial infection risks (80%) 
b13 = Suprarenal gland damage (15-35%) 
b14 = Diarrhea (10%) 
b15 = Sexual desire loss (15-35%) 
b16 = Body hair loss (70%) 
b17 = Weight loss (50%) 
b18 = Increase of the thorax diameter (20%) 
b19 = Fever (40%) 
b20 = Malignant tumor development in the liver (5%) 
b21 = Rash and pimples (60%) 
b22 = Pain, inflammation and stiffness in the joints (30-40%) 
b23 = Nasal polyps (20%) 
b24 = Purulent nasal secretions (30%) 
b25 = Warmness in the joints (30-40%) 
b26 = Jaundice (70%) 
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b27 = Increase of the liver volume (50-60%) 
b28 = Ascites (60%) 
b29 = Digestive haemorrhage (40%) 
b30 = Encephalopathy (conscience alterations, sleep disorders, confusion, mood changes) (85%) 
b31 = Impotence (15-35%) 
b32 = Menstruation disorder and/or early menopause (15-35%) 
b33 = Varicose veins appearance (70%) 
b34 = Increase of the parotid glands’ size (15-35%) 
b35 = Polydipsia, polyphagia and polyuria (15-35%) 
b36 = Steatorrhea (70%) 
b37 = Sickness and vomiting (45%) 
b38 = Hypersensitivity in the paranasal womb (15%) 
b39 = Blurry vision (40%) 
b40 = Long cicatrisation of the wounds (50-60%) 
b41 = Numbness and frequent tingling on hands and feet (50-60%) 
b42 = Dry skin (70%) 
b43 = Frequent haemoptysis (40%) 
b44 = Intestinal obstruction (70%) 
 
Matrix [M*] 
Matrix [O]  
 
Taking back all the information in the model, general talking, we obtain two kinds of very valuable information 
for our aim in this research work. 
At first place, if we take a look to the information of the matrix [M], which is the one who links the symptoms 
with the diseases (effects linked to causes), it is showed that there are four symptoms (which are the increase of the 
bacterial infection risk, the digestive haemorrhage, menstruation disorder and/or early menopause and Steatorrhea) 
which are the causes of a lot more symptoms directly linked with other diseases showed before. This can cause real 
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problems in the medical diagnosis, due to the confusion the doctor makes when he does not know if they are 
primary symptoms or symptoms caused by other symptoms. In this research work, we have made a process, which 
makes it able to untie the primary symptoms form the secondary ones, and this is a great step for the diagnosing 
system.  
If we continue the analysis from the followed process and we take a look on the matrix [M*], we can observe that 
this matrix procures the real relation between one of the five crossed diseases (named causes) and the crossed 
accumulated symptoms which are produced. These diseases are extremely linked because the hereditary 
Hemochromatosis causes Arthritis, Cirrhosis, Diabetes and Fibrosis. The interaction between these five diseases is 
showed in the matrix [A].  
The matrix [M*] proposes a real effect measured between 0 and 1 from the analysed diseases on the symptoms 
they cause, considering the crossed and accumulated effect of possible interactions between the variables which 
constitute the rows and columns. We can observe that the detection of a Hemochromatosis and the detection of a 
possible cirrhosis or possible diabetes through their symptoms would result basic for the early diagnosis of 
hereditary Hemochromatosis. This consideration comes from the high values which are observed in the matrix [M*]. 
This matrix acquires the highest relevance because it expresses the level with which a specific disease can cause 
different specific symptoms. These results are extremely important because they will be used by the medical 
facultative to establish necessary actuation protocols for the diagnosis and treatment of the hereditary 
Hemochromatosis. For example, if a patient is presented to the practitioner suffering from symptoms such as: 
testicular atrophy, liver failure, sexual desire loss, weight loss, fever, rash and pimples, pain, inflammation, 
warmness and stiffness in the joints and encephalopathy, he has 87% possibilities to suffer from Arthritis and a 26% 
conditional possibility that this Arthritis is caused by a hereditary Hemochromatosis. 
To arrive to this conclusion we have selected the levels from the symptoms which are 0.8 or higher (80%) which 
show Arthritis (C2 row) from the matrix [M*]. The reason why we have taken the higher levels is because when a 
patient goes to the doctor, he/she normally tells about the most signifying symptoms suffered, forgetting the less 
important ones, in this way, the symptoms which can cause Arthritis and don’t overpass the 50% of incidence 
haven’t been considered. 
The model used in this research work concludes obtaining the matrix [O], also called forgotten effects matrix. It 
is the one, which gives us the information about the causality relations, which are not considered at diagnosing. The 
information contained in this matrix is maybe the most important, because it reminds us about symptoms, which are 
not taken into, account normally. The values in the matrix [O] represent the forgotten level that we have incurred at 
making the initial causality relation. In other words; the more careful the symptom-disease valuation will be made, 
the lower the forgotten levels will be. On the other side, the more things we will forget in the first step, and the 
higher the forgotten levels will appear. To sum up, this matrix [O] shows the symptoms, which have the risk to not 
being taken into account and not being linked to the disease. 
To show how this method works, we have raised the interactions to one of the matrix [O] elements. This relation 
represents the followed process and shows that the brought element, which causes that an apparently insignificant 
incidence, could drag indirect and accumulated effects. Therefore, we observe that, initially, there was not any 
symptomatology relation between suffering hereditary Hemochromatosis and malignant tumor development in the 
liver. The model used shows that the relation is connected through the liver failure. That is because 
Hemochromatosis causes liver failure, and liver failure causes malignant tumors. Initially, the incidence of the 
tumors being caused by Hemochromatosis is only a 10%, but the forgotten effect rises up to an 80%. 
This approach allows choosing symptoms, which show significantly a specific disease. The results help to make 
an early detection of a hidden disease through indirect symptoms. It is clear that the individual causality relations 
cannot solve the diagnosis problem, but analysing them together, we could make an advanced analysis of diseases 
with a difficult detection, even diseases hidden by other diseases. 
The most important symptoms we should look to diagnose the hereditary Hemochromatosis would be sickness 
and vomiting, fever, impotence, weight loss, encephalopathy, body hair loss, sexual desire loss, stomach ache, 
weakness and tiredness. 
Some of these symptoms are usually considered by the doctors at making the first diagnostics, but we can find 
ourselves in a situation where, for example, sexual desire loss or weakness and tiredness are not specific symptoms 
directly linked to the hereditary Hemochromatosis. Otherwise, if we add them to the rest of the symptomatology, 
they appear closely linked. This is why it is important for the doctors to have an actuation protocol starting from the 
elaboration of lists of common symptoms from different diseases hard to detect, in order to discover this kind of 
16   Anna Maria Gil-Lafuente /  Procedia Economics and Finance  22 ( 2015 )  10 – 19 
affections as soon as possible. 
4. Discussion 
This research work pretends to get to know all the linked symptomatologies which can be showed Emergent and 
Rare diseases through mathematical models. It will allow us to know the disease in all its phases and start the 
treatment as soon as possible. These uncommon diseases shows up in the late stages of the patient’s life, has quite 
ineffective treatments and its research has not been well funded. On the other hand, the problems in the diagnosis 
are caused by the similarity between its symptoms and other diseases’ symptoms. We tackle a mathematic model 
which can solve the early diagnosis and, as consequence, the earlier treatment. It is based in a searching process, 
which links different symptoms caused by different diseases with a common origin. The calculations obtained allow 
us to distinguish groups of symptoms which, raised together, allow us to detect a specific disease and reject other 
diseases, which could cause confusion while diagnosing. In summary, the mathematical models are useful to make 
an early and correct diagnostic without the need to make any genetic test or waiting for the late symptoms to appear. 
A better study of REDs will allow determining the type, form and stage of the disease in the short term. This will 
allow in the medium and long term, to diagnose corresponding rare diseases in order to prevent development of the 
disease in a more complex shape for the diagnosis, follow-up laboratory studies, as well as deaths. 
The research and innovative spillovers are intended to develop in two major stages. The first stage led by our 
pioneering medical team attends all the phases in the process of early diagnostics and treatment of rare and emergent 
diseases such as appearance, evolution and forecast, as well as their medical implications. The second stage led by 
the conjunct efforts of our engineering and economic teams consists in a profound analysis on the economic and 
financial consequences that the mentioned diseases have on UE health systems. The final objective of the research is 
to reach sustainable long-term wellbeing of the population, specifically the stages are: 
i. Improve the early diagnosis utilizing computing techniques and treatment of the information, so the people 
affected do not only get a longer life expectancy, but also an improved quality of life, while saving resources to 
the public finances.  The pretended research has its foundation on an exhaustive study of the common protocols 
in detection of rare and emergent diseases, putting special emphasis on some particular cases. A study on real 
life challenges and obstacles in the diagnostic process to patients presenting rare diseases it has also planned to 
be conducted. An exhaustive study comparing the existing situation in the EU, countries’ surrounding the EU 
and developing countries is going to be made. Then, both technical and economic analysis will be led to improve 
the medical diagnostic protocols, saving time in the detection of rare diseases and accelerating the treatment, in 
case there is. These improvements will rely on application of computation techniques based on hybrid 
information systems, which combine numeric and non-numeric analysis. The innovative idea is to facilitate the 
creation of simple computing programs for personnel who treat the patients at a first instance. To detect and refer 
a patient in an adequate and efficient way results as high priority for society and the general wellbeing of the 
population.  
 
ii. The second target of this research focus on the economic calculation and the savings that the early diagnose of 
rare diseases represent for the public health system and the patients. Effective diagnostics turn out in direct or 
indirect cost reduction. In order to complete that task, a field study will be carried out focusing on the next 
issues: 
 
 Public Health: 
1. Development of new tests or protocols utilizing new information technologies that their cost is null or 
residual.  
2. Reduction on the number of admissions or time spent in hospitals due to the efficiency on the 
diagnostics. 
3. Reduction on the number of medical consults, eliminating duplicate tests or repetitive specialists refers. 
4. Reduction on the number of diagnostic trials, suppressing duplicities and repetition due to the delay in 
diagnostics.  
5. With an effective diagnose, the patients could improve their quality of life, and still be part of the active 
population.  
 Labour Costs: 
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1. Correct utilization of medical insurance and the reduction of costs for the labour assurances.  
2. Reduction on costs for work absence due to repetitive visits to health facilities.  
 Quality of life: 
1. Better conditions for the patients. Early treatment supposes better conditions and life expectancy. 
2. Reduction on personal and familiar costs due to treatment, therapies, diagnostic trials, etc. 
3. Reduction on dependency costs, providing early diagnose means better quality of life.  
4. Reduction on visits and consults to health facilities, therefore decreasing work absence.  
 
Appendix A. An example appendix 
 
Matrix [B] 
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